Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104
Grace Therapeutics announced that the FDA has issued a Complete Response Letter regarding the New Drug Application for GTx-104, a novel injectable nimodipine formulation for aneurysmal subarachnoid hemorrhage (aSAH). The FDA cited issues related to chemistry, manufacturing controls, and non-clinical information but did not request more clinical dat…